Philip Blake Appointed New Chairman, Rx&D Board of Directors

OTTAWA, Nov. 16, 2011 /CNW/ - Canada's Research-Based Pharmaceutical Companies (Rx&D) is pleased to announce the appointment of Philip Blake, President and Chief Executive Officer (CEO) of Bayer Inc., as Chairman of the Board of Directors for 2011 - 2012. Mr. Blake assumed the Board chairmanship during today's Rx&D Annual General meeting held in Gatineau.

Mr. Blake is a member of Rx&D's Executive Committee and Board of Directors. Until becoming Board Chairman, he fulfilled the roles of First Vice-Chair, Board of Directors; Chair, of the Atlantic Committee; Member of the Membership Committee, By-Laws Committee, Nominating Committee & HR Committee. Mr. Blake was first elected in 2000 and became a member of Executive Committee in 2003. He served as Chair of the association in 2007. He was re-elected in 2008 for a full three-year term to the Rx&D Board.

"The research-based pharmaceutical industry makes an important contribution to the quality of life of all Canadians by discovering and developing the new medicines vaccines and biologics that have allowed us to live longer and in better health. I am very honoured to once again lead the Rx&D Board", says Mr. Blake.

"Canadians will continue to benefit from the research-based pharmaceutical industry's role as a leader in R&D and innovation as we search for life-saving treatments. We never forget that patients are at the heart of our drive for innovative medicines."

Philip Blake

Philip Blake is President & CEO, Bayer Inc. and Head of Bayer HealthCare in Canada. Under his leadership, the organization has become one of the country's top five healthcare companies, and has been named one of Canada's Top 100 Employers for the past 5 years running as well as one of Canada's Greenest Employers for the past 3 years. Bayer is headquartered in Toronto and Calgary, employing approximately 1100 professionals from coast to coast.

Mr. Blake was appointed President & CEO of Bayer Inc. in 2002. In his 30 year career with Bayer, Mr. Blake has held leadership positions around the world focusing on global strategic product marketing, business development, clinical planning, product developments and sales management. He was also responsible for the successful integration of a major Canadian pharmaceuticals company into Bayer's pharmaceutical business in Canada.

In 2006, Mr. Blake was inducted into the Canadian Pharmaceutical Marketing Hall of Fame and in 2008 was named Communicator of the Year by the International Association of Business Communicators (IABC).

About Rx&D

Rx&D is the association of leading research-based pharmaceutical companies dedicated to improving the health of Canadians through the discovery and development of new medicines and vaccines. Our community represents 15,000 men and women working for 50 member companies and invests more than $1 billion in research and development each year to fuel Canada's knowledge-based economy. Guided by our Code of Ethical Practices, our membership is committed to working in partnership with governments, healthcare professionals and stakeholders in a highly ethical manner.

SOURCE CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX

For further information:

Christine Choury,
Media Relations
Telephone: 613-236-0455
E-mail: cchoury@canadapharma.org

Profil de l'entreprise

CANADA'S RESEARCH-BASED PHARMACEUTICAL COMPANIES (RX&D)

Renseignements sur cet organisme


FORFAITS PERSONNALISÉS

Jetez un coup d’œil sur nos forfaits personnalisés ou créez le vôtre selon vos besoins de communication particuliers.

Commencez dès aujourd'hui .

ADHÉSION À CNW

Remplissez un formulaire d'adhésion à CNW ou communiquez avec nous au 1-877-269-7890.

RENSEIGNEZ-VOUS SUR LES SERVICES DE CNW

Demandez plus d'informations sur les produits et services de CNW ou communiquez avec nous au 1‑877-269-7890.